| dbo:abstract
|
- Brian M. Stoltz is currently a professor of chemistry at the California Institute of Technology. The primary focus of his research is chemical synthesis with an emphasis on expanding the scope of allylic alkylation for the preparation of complex molecules possessing unique structural, biological, and physical properties. His research involves the total synthesis of natural products such as dragmacidin F and (–)-cyanthiwigin F, and development of synthetic reactions to access quaternary stereocenters. Specifically, he has focused on the allylic alkylation of enolates, developing an enantioselective variant in 2004. (en)
|
| dbo:academicAdvisor
| |
| dbo:academicDiscipline
| |
| dbo:almaMater
| |
| dbo:award
| |
| dbo:birthDate
| |
| dbo:birthName
| |
| dbo:doctoralAdvisor
| |
| dbo:doctoralStudent
| |
| dbo:nationality
| |
| dbo:thumbnail
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 7151 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:academicAdvisors
| |
| dbp:almaMater
|
- Yale (en)
- Indiana University of Pennsylvania( ) (en)
|
| dbp:birthDate
| |
| dbp:birthName
| |
| dbp:doctoralAdvisor
| |
| dbp:doctoralStudents
|
- (en)
- Hosea Nelson (en)
- Jennifer Roizen (en)
- Neil Garg (en)
- Richmond Sarpong (en)
|
| dbp:field
| |
| dbp:name
| |
| dbp:nationality
| |
| dbp:prizes
| |
| dbp:wikiPageUsesTemplate
| |
| dbp:workInstitutions
| |
| dcterms:subject
| |
| rdf:type
| |
| rdfs:comment
|
- Brian M. Stoltz is currently a professor of chemistry at the California Institute of Technology. The primary focus of his research is chemical synthesis with an emphasis on expanding the scope of allylic alkylation for the preparation of complex molecules possessing unique structural, biological, and physical properties. His research involves the total synthesis of natural products such as dragmacidin F and (–)-cyanthiwigin F, and development of synthetic reactions to access quaternary stereocenters. Specifically, he has focused on the allylic alkylation of enolates, developing an enantioselective variant in 2004. (en)
|
| rdfs:label
| |
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
| |
| is dbo:academicAdvisor
of | |
| is dbo:doctoralAdvisor
of | |
| is dbo:notableStudent
of | |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is dbp:doctoralAdvisor
of | |
| is foaf:primaryTopic
of | |
